Health Care & Life Sciences » Biotechnology | NanoString Technologies Inc.

NanoString Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
42,656.00
72,225.00
49,044.00
74,036.00
77,555.00
93,997
Total Accounts Receivable
8,331.00
12,436.00
19,725.00
22,379.00
19,564.00
17,279
Inventories
8,327.00
7,651.00
11,802.00
15,074.00
20,057.00
13,173
Other Current Assets
1,422.00
3,035.00
2,222.00
2,296.00
4,745.00
7,258
Total Current Assets
60,736.00
95,347.00
82,793.00
113,785.00
121,921.00
131,707
Net Property, Plant & Equipment
3,065.00
6,366.00
9,414.00
12,158.00
14,057.00
15,171
Total Investments and Advances
201.00
143.00
143.00
143.00
143.00
-
Other Assets
370.00
892.00
519.00
287.00
641.00
680
Total Assets
64,372.00
102,748.00
92,869.00
126,373.00
136,762.00
147,558
ST Debt & Current Portion LT Debt
6,136.00
251.00
226.00
58.00
-
Accounts Payable
3,354.00
3,380.00
3,243.00
4,935.00
4,092.00
Income Tax Payable
-
-
551.00
420.00
-
Other Current Liabilities
9,140.00
15,177.00
16,891.00
30,970.00
31,827.00
Total Current Liabilities
18,630.00
18,808.00
20,911.00
36,383.00
35,919.00
Long-Term Debt
12,157.00
30,675.00
41,000.00
47,366.00
48,931.00
Other Liabilities
2,116.00
8,452.00
10,743.00
30,319.00
11,803.00
Total Liabilities
32,903.00
57,935.00
72,654.00
114,068.00
96,653.00
Common Equity (Total)
31,469.00
44,813.00
20,215.00
12,305.00
40,109.00
Total Shareholders' Equity
31,469.00
44,813.00
20,215.00
12,305.00
40,109.00
Total Equity
31,469.00
44,813.00
20,215.00
12,305.00
40,109.00
Liabilities & Shareholders' Equity
64,372.00
102,748.00
92,869.00
126,373.00
136,762.00

About NanoString Technologies

View Profile
Address
530 Fairview Avenue North
Seattle Washington 98109
United States
Employees -
Website http://www.nanostring.com
Updated 07/08/2019
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.